Both in Surgical Instruments
Cytosorbents vs PAVmed
Over the past year CTSO returned −71.2% and PAVM returned −85.3%; their daily moves had a correlation of 0.08.
CTSO −71.2% PAVM −85.3%Growth of $1, one year, split-adjusted
| Metric | CTSO | PAVM |
|---|---|---|
| Price | $4.56 | $1.66 |
| Market cap | $14.4M | $13.3M |
| Today | +0.44% | −8.79% |
| 1 month | +15.2% | −37.9% |
| 6 months | −60.0% | −76.3% |
| Year to date | −64.3% | −74.9% |
| 1 year | −70.8% | −86.2% |
| Revenue growth (YoY) | +0.2% | +450.0% |
| Gross margin | 73.2% | −269.7% |
| Net margin | −45.9% | −16603.0% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 118.5× |
| Net cash | -$12.8M | -$11.3M |
| Dividend yield | — | — |
| Volatility (60d) | 881.4% | 101.7% |
| Short % of float | 0.2% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).